Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Regier

Showing results (161-170 of 301) with videos related to

Pageof 31
Sort By:
Schizophrenia Bulletin|December 21, 2007
Use of depot antipsychotic medications for medication nonadherence in schizophreniaJoyce C West, Steven C Marcus, Joshua Wilk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential SolutionsSarah Wordsworth, Brett Doble, Katherine Payne, et al.
Health Policy Quarterly|March 7, 1983
Uses of ambulatory health/mental health utilization data in organized health care settingsB J Burns, I D Goldberg, J Hankin, et al.
Psychiatric Services (Washington, D.C.)|August 3, 2011
Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severityDavid J Katzelnick, Farifteh Firoozmand Duffy, Henry Chung, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation ModelingDeborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
British Journal of Haematology|April 22, 2016
Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemiaSonya Cressman, Aly Karsan, Donna E Hogge, et al.
Archives of General Psychiatry|February 1, 1982
Specialist/generalist division of responsibility for patients with mental disordersD A Regier, I D Goldberg, B J Burns, et al.
Journal of Clinical Epidemiology|March 20, 2012
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropeniaLillian Sung, Shabbir M Alibhai, Marie-Chantal Ethier, et al.
Archives of General Psychiatry|February 1, 1993
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and servicesD A Regier, W E Narrow, D S Rae, et al.
The American Journal of Psychiatry|November 1, 1988
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basisD A Regier, R M Hirschfeld, F K Goodwin, et al.
Pageof 31

Showing results (161-170 of 301) with videos related to

Sort By:
Pageof 31
Schizophrenia Bulletin|December 21, 2007
Use of depot antipsychotic medications for medication nonadherence in schizophreniaJoyce C West, Steven C Marcus, Joshua Wilk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential SolutionsSarah Wordsworth, Brett Doble, Katherine Payne, et al.
Health Policy Quarterly|March 7, 1983
Uses of ambulatory health/mental health utilization data in organized health care settingsB J Burns, I D Goldberg, J Hankin, et al.
Psychiatric Services (Washington, D.C.)|August 3, 2011
Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severityDavid J Katzelnick, Farifteh Firoozmand Duffy, Henry Chung, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation ModelingDeborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
British Journal of Haematology|April 22, 2016
Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemiaSonya Cressman, Aly Karsan, Donna E Hogge, et al.
Archives of General Psychiatry|February 1, 1982
Specialist/generalist division of responsibility for patients with mental disordersD A Regier, I D Goldberg, B J Burns, et al.
Journal of Clinical Epidemiology|March 20, 2012
Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropeniaLillian Sung, Shabbir M Alibhai, Marie-Chantal Ethier, et al.
Archives of General Psychiatry|February 1, 1993
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and servicesD A Regier, W E Narrow, D S Rae, et al.
The American Journal of Psychiatry|November 1, 1988
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basisD A Regier, R M Hirschfeld, F K Goodwin, et al.
Pageof 31